drs. J.M. van Rooijen

No picture available
E-mail:
j.m.van.rooijen umcg.nl

Research

Publications
  1. Circulating tumor DNA guided adjuvant chemotherapy in stage II colon cancer (MEDOCC-CrEATE): study protocol for a trial within a cohort study

    PLCRC-MEDOCC group, Schraa, S. J., van Rooijen, K. L., van der Kruijssen, D. E. W., Rubio Alarcón, C., Phallen, J., Sausen, M., Simmons, J., Coupé, V. M. H., van Grevenstein, W. M. U., Elias, S., Verkooijen, H. M., Laclé, M. M., Bosch, L. J. W., van den Broek, D., Meijer, G. A., Velculescu, V. E., Fijneman, R. J. A., Vink, G. R. & Koopman, M., 20-Aug-2020, In : BMC Cancer. 20, 1, 10 p., 790.

    Research output: Contribution to journalArticleAcademicpeer-review

  2. High hepatocyte growth factor expression in primary tumor predicts better overall survival in male breast cancer

    Qiu, S-Q., van Rooijen, J., Nienhuis, H. H., van der Vegt, B., Timmer-Bosscha, H., van Leeuwen-Stok, E., Walenkamp, A. M. E., van Deurzen, C. H. M., de Bock, G. H., de Vries, E. G. E. & Schroder, C. P., 18-Mar-2020, In : Breast cancer research. 22, 1, 10 p., 30.

    Research output: Contribution to journalArticleAcademicpeer-review

  3. Immunotherapeutic options on the horizon in breast cancer treatment

    van Rooijen, J. M., Stutvoet, T. S., Schröder, C. P. & de Vries, E. G. E., Dec-2015, In : Pharmacology & Therapeutics. 156, p. 90-101 12 p.

    Research output: Contribution to journalReview articleAcademicpeer-review

View all (4) »

ID: 95078182